Lonza, Eclipse JV production cancer therapeutic antibody

Lonza, Eclipse JV for production of cancer therapeutic antibody

10:02 PM, 29th February 2012
Lonza, Eclipse JV for production of cancer therapeutic antibody
Lonza headquarters in Switzerland.

BASEL, SWITZERLAND/CALIFORNIA, US: Lonza and Eclipse Therapeutics announced an agreement for the production of Eclipse’s novel cancer therapeutic antibody, ET-101, using Light Path Development Services. ET-101 is under investigation for the inhibition of the growth of cancer stem cells. Under the agreement, Lonza will produce phase 1 clinical material at its development and manufacturing facility in Slough, UK. Eliminating cancer stem cells represents a new cancer treatment paradigm that could offer a distinct advantage over existing strategies and a solution for chemoresistance.

“Lonza’s best-in-class antibody manufacturing capabilities will greatly support our development strategy to deliver the highest quality and most effective therapeutics targeting cancer stem cells. Moving into cell line development and subsequent manufacturing represents an important milestone for Eclipse,” said Dr Christopher Reyes, Chief Security Officer, Eclipse Therapeutics.

© WOC News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

South Korea delays its decision on carbon emission trading system

SEOUL, SOUTH KOREA: South Korea’s parliament has delayed vote on an emission trading scheme scheduled, because of political wrangling between ...

Read more
Mitsui Chemicals to provide TDI-MDI technology license to SABIC

TOKYO, JAPAN/ RIYADH, SAUDI ARABIA: The Saudi Basic Industries Corporation (SABIC) has signed a toluene diisocyanate (TDI) and methylene di-para-pheny ...

Read more
EPSRC invites research proposals for graphene engineering

SWINDON, UK: EPSRC invites expressions of interests to bid into the call for proposals in graphene engineering research. The aim of the call is to foc ...

Read more
DuPont, ACPFG form joint venture for crop productivity

DES MOINES, US/ADELAIDE, AUSTRALIA: DuPont and the Australian Centre for Plant Functional Genomics (ACPFG) announced that they have expanded their lon ...

Read more
SNF India to tap Indian specialty chemicals market

VISAKHAPATNAM, INDIA: Recently, SNF India formally inaugurated its new chemical plant set up in the Jawaharlal Nehru Pharma city in Visakhapatnam dist ...

Read more
Explosion at Hebei Zhaoxian Keeper Chemical plant in China kills 16

SHIJIAZHUANG, CHINA: The death toll in chemical plant explosion has climbed to 16, and 43 others were hospitalized with injuries, authorities in north ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X